लोड हो रहा है...
Acquired Hemophilia A Successfully Treated with Rituximab
Acquired hemophilia A (AHA) is a rare bleeding disorder due to the development of specific autoantibodies against factor VIII. The anti-CD20 monoclonal antibody Rituximab has been proven to be effective in obtaining a long-term suppression of inhibitors of AHA, besides other immunosuppressive standa...
में बचाया:
| में प्रकाशित: | Mediterr J Hematol Infect Dis |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Università Cattolica del Sacro Cuore
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4344169/ https://ncbi.nlm.nih.gov/pubmed/25745551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2015.024 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|